Follow this preprint
Cost-effective boosting allocations in the post-Omicron era of COVID-19 management
View ORCID ProfileThao P. Le, View ORCID ProfileEamon Conway, View ORCID ProfileEdifofon Akpan, View ORCID ProfileIsobel Abell, View ORCID ProfilePatrick Abraham, View ORCID ProfileChristopher M. Baker, View ORCID ProfilePatricia T. Campbell, View ORCID ProfileDeborah Cromer, View ORCID ProfileMichael J. Lydeamore, Yasmine McDonough, View ORCID ProfileIvo Mueller, View ORCID ProfileGerard Ryan, View ORCID ProfileCamelia Walker, Yingying Wang, View ORCID ProfileNatalie Carvalho, View ORCID ProfileJodie McVernon
doi: https://doi.org/10.1101/2023.11.14.23298536
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Thao P. Le
aSchool of Mathematics and Statistics, The University of Melbourne, Melbourne, 3010, Victoria, Australia
bMelbourne Centre for Data Science, The University of Melbourne, Melbourne, 3010, Victoria, Australia
cCentre of Excellence for Biosecurity Risk Analysis, The University of Melbourne, Melbourne, 3010, Victoria, Australia
Eamon Conway
dPopulation Health & Immunity Division, Walter and Eliza Hall Institute of Medical Research, Melbourne, 3052, Victoria, Australia
Edifofon Akpan
eMelbourne School of Population and Global Health, The University of Melbourne, Melbourne, 3010, Victoria, Australia
Isobel Abell
aSchool of Mathematics and Statistics, The University of Melbourne, Melbourne, 3010, Victoria, Australia
bMelbourne Centre for Data Science, The University of Melbourne, Melbourne, 3010, Victoria, Australia
Patrick Abraham
eMelbourne School of Population and Global Health, The University of Melbourne, Melbourne, 3010, Victoria, Australia
Christopher M. Baker
aSchool of Mathematics and Statistics, The University of Melbourne, Melbourne, 3010, Victoria, Australia
bMelbourne Centre for Data Science, The University of Melbourne, Melbourne, 3010, Victoria, Australia
cCentre of Excellence for Biosecurity Risk Analysis, The University of Melbourne, Melbourne, 3010, Victoria, Australia
Patricia T. Campbell
eMelbourne School of Population and Global Health, The University of Melbourne, Melbourne, 3010, Victoria, Australia
fDepartment of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, 3010, Victoria, Australia
Deborah Cromer
gKirby Institute, University of New South Wales, Sydney, 2052, New South Wales, Australia
Michael J. Lydeamore
hDepartment of Econometrics and Business Statistics, Monash University, Melbourne, 3800, Victoria, Australia
Yasmine McDonough
dPopulation Health & Immunity Division, Walter and Eliza Hall Institute of Medical Research, Melbourne, 3052, Victoria, Australia
Ivo Mueller
dPopulation Health & Immunity Division, Walter and Eliza Hall Institute of Medical Research, Melbourne, 3052, Victoria, Australia
iDepartment of Medical Biology, The University of Melbourne, Melbourne, 3010, Victoria, Australia
Gerard Ryan
eMelbourne School of Population and Global Health, The University of Melbourne, Melbourne, 3010, Victoria, Australia
jTelethon Kids Institute, Nedlands, 6009, Western Australia, Australia
Camelia Walker
aSchool of Mathematics and Statistics, The University of Melbourne, Melbourne, 3010, Victoria, Australia
Yingying Wang
eMelbourne School of Population and Global Health, The University of Melbourne, Melbourne, 3010, Victoria, Australia
Natalie Carvalho
eMelbourne School of Population and Global Health, The University of Melbourne, Melbourne, 3010, Victoria, Australia
Jodie McVernon
fDepartment of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, 3010, Victoria, Australia
kVictorian Infectious Diseases Reference Laboratory Epidemiology Unit at the Peter Doherty Institute for Infection and Immunity, The Royal Melbourne Hospital, Melbourne, 3010, Victoria, Australia

Posted November 15, 2023.
Cost-effective boosting allocations in the post-Omicron era of COVID-19 management
Thao P. Le, Eamon Conway, Edifofon Akpan, Isobel Abell, Patrick Abraham, Christopher M. Baker, Patricia T. Campbell, Deborah Cromer, Michael J. Lydeamore, Yasmine McDonough, Ivo Mueller, Gerard Ryan, Camelia Walker, Yingying Wang, Natalie Carvalho, Jodie McVernon
medRxiv 2023.11.14.23298536; doi: https://doi.org/10.1101/2023.11.14.23298536
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Subject Area
Subject Areas
- Addiction Medicine (410)
- Allergy and Immunology (722)
- Anesthesia (214)
- Cardiovascular Medicine (3063)
- Dermatology (259)
- Emergency Medicine (459)
- Epidemiology (12995)
- Forensic Medicine (13)
- Gastroenterology (856)
- Genetic and Genomic Medicine (4803)
- Geriatric Medicine (443)
- Health Economics (749)
- Health Informatics (3043)
- Health Policy (1099)
- Hematology (406)
- HIV/AIDS (954)
- Medical Education (452)
- Medical Ethics (119)
- Nephrology (496)
- Neurology (4576)
- Nursing (243)
- Nutrition (678)
- Oncology (2373)
- Ophthalmology (671)
- Orthopedics (266)
- Otolaryngology (332)
- Pain Medicine (298)
- Palliative Medicine (86)
- Pathology (514)
- Pediatrics (1235)
- Primary Care Research (516)
- Public and Global Health (7159)
- Radiology and Imaging (1592)
- Respiratory Medicine (941)
- Rheumatology (457)
- Sports Medicine (400)
- Surgery (507)
- Toxicology (64)
- Transplantation (218)
- Urology (188)